[HTML][HTML] Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: systematic review and …
E Valeriani, E Porreca, JI Weitz, S Schulman… - Journal of Thrombosis …, 2020 - Elsevier
Abstract Background Direct oral anticoagulants (DOACs) are recommended over vitamin K
antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant …
antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant …
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism
M Giustozzi, L Franco, MC Vedovati, C Becattini… - Journal of thrombosis …, 2019 - Springer
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality worldwide.
For decades, low molecular weight heparins (LMWH) and vitamin K-antagonists have been …
For decades, low molecular weight heparins (LMWH) and vitamin K-antagonists have been …
[引用][C] Direct oral anticoagulants versus conventional anticoagulants for pulmonary embolism
B Long, M Gottlieb - Academic Emergency Medicine, 2023 - Wiley Online Library
Direct Oral Anticoagulants Versus Conventional Anticoagulants for Pulmonary Embolism
Page 1 Long Brit (Orcid ID: 0000-0003-4770-8869) Gottlieb Michael (Orcid ID: 0000-0003-3276-8375) …
Page 1 Long Brit (Orcid ID: 0000-0003-4770-8869) Gottlieb Michael (Orcid ID: 0000-0003-3276-8375) …
Pulmonary embolism: current and new treatment options
Background: Pulmonary embolism (PE) can be a life-threatening emergency. Accurate
diagnostic techniques and patient-specific management strategies are necessary to ensure …
diagnostic techniques and patient-specific management strategies are necessary to ensure …
Anticoagulation in pulmonary embolism: update in the age of direct oral anticoagulants
R Rosovsky, G Merli - Techniques in Vascular and Interventional Radiology, 2017 - Elsevier
The emergence of direct oral anticoagulants (DOACs) represents a major advancement and
paradigm shift in the treatment of venous thromboembolism. Currently, dabigatran …
paradigm shift in the treatment of venous thromboembolism. Currently, dabigatran …
Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism
R Ghazvinian, A Gottsäter, JL Elf - Journal of thrombosis and thrombolysis, 2018 - Springer
Anticoagulant treatment of acute pulmonary embolism (PE) has traditionally been hospital-
based. The lesser need for monitoring with the increasingly used direct acting oral …
based. The lesser need for monitoring with the increasingly used direct acting oral …
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature
F Dentali, MND Di Minno, M Gianni… - Internal and emergency …, 2015 - Springer
Limited information exists on the safety and efficacy of non-vitamin K oral anticoagulants
(NOACs) in patients with pulmonary embolism (PE). The aim of this study is to evaluate the …
(NOACs) in patients with pulmonary embolism (PE). The aim of this study is to evaluate the …
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus, V Wang… - PloS one, 2018 - journals.plos.org
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study
H Badreldin - Journal of Thrombosis and Thrombolysis, 2018 - Springer
This study was conducted to describe the real-world hospital length of stay in patients
treated with all of the US Food and Drug Administration approved direct oral anticoagulants …
treated with all of the US Food and Drug Administration approved direct oral anticoagulants …